{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:21:11Z","timestamp":1789608071468,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"AbbVie and the National Research Foundation of Korea","award":["NRF-2017R1D1A1B03031924"],"award-info":[{"award-number":["NRF-2017R1D1A1B03031924"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"DOI":"10.1186\/s13099-024-00637-5","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T06:02:17Z","timestamp":1724652137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dynamic changes in the gut microbiota composition during adalimumab therapy in patients with ulcerative colitis: implications for treatment response prediction and therapeutic targets"],"prefix":"10.1186","volume":"16","author":[{"given":"Han Na","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Yong","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihye","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Moon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Kyoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonyong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jun","family":"Sul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hwan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"issue":"27","key":"637_CR1","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.3748\/wjg.v22.i27.6296","volume":"22","author":"AT Abegunde","year":"2016","unstructured":"Abegunde AT, Muhammad BH, Bhatti O, Ali T. Environmental risk factors for inflammatory bowel diseases: evidence based literature review. World J Gastroenterol. 2016;22(27):6296\u2013317. https:\/\/doi.org\/10.3748\/wjg.v22.i27.6296.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"637_CR2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/ecco-jcc\/jjw223","volume":"11","author":"C Maaser","year":"2017","unstructured":"Maaser C, Langholz E, Gordon H, Burisch J, Ellul P, Ramirez VH, et al. European Crohn\u2019s and colitis organisation topical review on environmental factors in IBD. J Crohns Colitis. 2017;11(8):905\u201320. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw223.","journal-title":"J Crohns Colitis"},{"issue":"9","key":"637_CR3","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/mib.0000000000001217","volume":"23","author":"KWJ van der Sloot","year":"2017","unstructured":"van der Sloot KWJ, Amini M, Peters V, Dijkstra G, Alizadeh BZ. Inflammatory bowel diseases: review of known environmental protective and risk factors involved. Inflamm Bowel Dis. 2017;23(9):1499\u2013509. https:\/\/doi.org\/10.1097\/mib.0000000000001217.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"637_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","volume":"152","author":"GG Kaplan","year":"2017","unstructured":"Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152(2):313-21.e2. https:\/\/doi.org\/10.1053\/j.gastro.2016.10.020.","journal-title":"Gastroenterology"},{"issue":"10","key":"637_CR5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/apt.14338","volume":"46","author":"CN Bernstein","year":"2017","unstructured":"Bernstein CN. Review article: changes in the epidemiology of inflammatory bowel disease-clues for aetiology. Aliment Pharmacol Ther. 2017;46(10):911\u20139. https:\/\/doi.org\/10.1111\/apt.14338.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"637_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","volume":"15","author":"AN Ananthakrishnan","year":"2018","unstructured":"Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, et al. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15(1):39\u201349. https:\/\/doi.org\/10.1038\/nrgastro.2017.136.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"637_CR7","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/ecco-jcc\/jjz081","volume":"13","author":"SH Park","year":"2019","unstructured":"Park SH, Kim YJ, Rhee KH, Kim YH, Hong SN, Kim KH, et al. A 30-year trend analysis in the epidemiology of inflammatory bowel disease in the Songpa-Kangdong district of Seoul, Korea in 1986\u20132015. J Crohns Colitis. 2019;13(11):1410\u20137. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz081.","journal-title":"J Crohns Colitis"},{"issue":"9853","key":"637_CR8","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/s0140-6736(12)60150-0","volume":"380","author":"I Ord\u00e1s","year":"2012","unstructured":"Ord\u00e1s I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380(9853):1606\u201319. https:\/\/doi.org\/10.1016\/s0140-6736(12)60150-0.","journal-title":"Lancet"},{"issue":"10","key":"637_CR9","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.ijsu.2013.08.019","volume":"11","author":"J Ahmed","year":"2013","unstructured":"Ahmed J, Reddy BS, M\u00f8lbak L, Leser TD, MacFie J. Impact of probiotics on colonic microflora in patients with colitis: a prospective double blind randomised crossover study. Int J Surg. 2013;11(10):1131\u20136. https:\/\/doi.org\/10.1016\/j.ijsu.2013.08.019.","journal-title":"Int J Surg"},{"issue":"6","key":"637_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/MOG.0b013e32833f1195","volume":"26","author":"J Hansen","year":"2010","unstructured":"Hansen J, Gulati A, Sartor RB. The role of mucosal immunity and host genetics in defining intestinal commensal bacteria. Curr Opin Gastroenterol. 2010;26(6):564\u201371. https:\/\/doi.org\/10.1097\/MOG.0b013e32833f1195.","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"637_CR11","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1053\/j.gastro.2019.07.025","volume":"157","author":"K Aden","year":"2019","unstructured":"Aden K, Rehman A, Waschina S, Pan WH, Walker A, Lucio M, et al. Metabolic functions of gut microbes associate with efficacy of tumor necrosis factor antagonists in patients with inflammatory bowel diseases. Gastroenterology. 2019;157(5):1279-92.e11. https:\/\/doi.org\/10.1053\/j.gastro.2019.07.025.","journal-title":"Gastroenterology"},{"issue":"8","key":"637_CR12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/ecco-jcc\/jjw051","volume":"10","author":"MK Magnusson","year":"2016","unstructured":"Magnusson MK, Strid H, Sapnara M, Lasson A, Bajor A, Ung KA, et al. Anti-TNF therapy response in patients with ulcerative colitis is associated with colonic antimicrobial peptide expression and microbiota composition. J Crohns Colitis. 2016;10(8):943\u201352. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw051.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"637_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.chom.2017.04.010","volume":"21","author":"AN Ananthakrishnan","year":"2017","unstructured":"Ananthakrishnan AN, Luo C, Yajnik V, Khalili H, Garber JJ, Stevens BW, et al. Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases. Cell Host Microbe. 2017;21(5):603-10.e3. https:\/\/doi.org\/10.1016\/j.chom.2017.04.010.","journal-title":"Cell Host Microbe"},{"issue":"26","key":"637_CR14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/nejm198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317(26):1625\u20139. https:\/\/doi.org\/10.1056\/nejm198712243172603.","journal-title":"N Engl J Med."},{"issue":"2","key":"637_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00535-013-0922-y","volume":"49","author":"Y Suzuki","year":"2014","unstructured":"Suzuki Y, Motoya S, Hanai H, Matsumoto T, Hibi T, Robinson AM, et al. Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis. J Gastroenterol. 2014;49(2):283\u201394. https:\/\/doi.org\/10.1007\/s00535-013-0922-y.","journal-title":"J Gastroenterol"},{"issue":"8","key":"637_CR16","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.dld.2018.03.007","volume":"50","author":"C Mu\u00f1oz-Villafranca","year":"2018","unstructured":"Mu\u00f1oz-Villafranca C, Ortiz de Zarate J, Arreba P, Higuera R, G\u00f3mez L, Ib\u00e1\u00f1ez S, et al. Adalimumab treatment of anti-TNF-na\u00efve patients with ulcerative colitis: deep remission and response factors. Dig Liver Dis. 2018;50(8):812\u20139. https:\/\/doi.org\/10.1016\/j.dld.2018.03.007.","journal-title":"Dig Liver Dis."},{"issue":"1","key":"637_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5217\/ir.2018.00126","volume":"17","author":"T Fukuda","year":"2019","unstructured":"Fukuda T, Naganuma M, Kanai T. Current new challenges in the management of ulcerative colitis. Intest Res. 2019;17(1):36\u201344. https:\/\/doi.org\/10.5217\/ir.2018.00126.","journal-title":"Intest Res"},{"issue":"2","key":"637_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/j.gastro.2011.10.032","volume":"142","author":"WJ Sandborn","year":"2012","unstructured":"Sandborn WJ, van Assche G, Reinisch W, Colombel JF, D\u2019Haens G, Wolf DC, et al. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2012;142(2):257\u201365. https:\/\/doi.org\/10.1053\/j.gastro.2011.10.032.","journal-title":"Gastroenterology."},{"key":"637_CR19","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2021.00049","author":"SY Shin","year":"2021","unstructured":"Shin SY, Park SJ, Kim Y, Im JP, Kim HJ, Lee KM, et al. Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study. Intest Res. 2021. https:\/\/doi.org\/10.5217\/ir.2021.00049.","journal-title":"Intest Res"},{"issue":"1","key":"637_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/ecco-jcc\/jjv169","volume":"10","author":"A B\u00e1lint","year":"2016","unstructured":"B\u00e1lint A, Farkas K, Palatka K, Lakner L, Miheller P, R\u00e1cz I, et al. Efficacy and safety of adalimumab in ulcerative colitis refractory to conventional therapy in routine clinical practice. J Crohns Colitis. 2016;10(1):26\u201330. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv169.","journal-title":"J Crohns Colitis"},{"issue":"8","key":"637_CR21","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/ismej.2012.8","volume":"6","author":"JG Caporaso","year":"2012","unstructured":"Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012;6(8):1621\u20134. https:\/\/doi.org\/10.1038\/ismej.2012.8.","journal-title":"ISME J"},{"issue":"8","key":"637_CR22","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852\u20137. https:\/\/doi.org\/10.1038\/s41587-019-0209-9.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"637_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: high-resolution sample inference from illumina amplicon data. Nat Methods. 2016;13(7):581\u20133. https:\/\/doi.org\/10.1038\/nmeth.3869.","journal-title":"Nat Methods"},{"issue":"4","key":"637_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30(4):772\u201380. https:\/\/doi.org\/10.1093\/molbev\/mst010.","journal-title":"Mol Biol Evol"},{"issue":"6","key":"637_CR25","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/molbev\/msy096","volume":"35","author":"S Kumar","year":"2018","unstructured":"Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35(6):1547\u20139. https:\/\/doi.org\/10.1093\/molbev\/msy096.","journal-title":"Mol Biol Evol"},{"issue":"W1","key":"637_CR26","doi-asserted-by":"publisher","first-page":"W293","DOI":"10.1093\/nar\/gkab301","volume":"49","author":"I Letunic","year":"2021","unstructured":"Letunic I, Bork P. Interactive tree of life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49(W1):W293\u20136. https:\/\/doi.org\/10.1093\/nar\/gkab301.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"637_CR27","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60.","journal-title":"Genome Biol"},{"issue":"5","key":"637_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/ecco-jcc\/jjw041","volume":"10","author":"K Papamichael","year":"2016","unstructured":"Papamichael K, Cheifetz AS. Higher adalimumab drug levels are associated with mucosal healing in patients with Crohn\u2019s disease. J Crohns Colitis. 2016;10(5):507\u20139. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw041.","journal-title":"J Crohns Colitis"},{"issue":"2","key":"637_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/mib.0000000000000689","volume":"22","author":"AJ Yarur","year":"2016","unstructured":"Yarur AJ, Jain A, Hauenstein SI, Quintero MA, Barkin JS, Deshpande AR, et al. Higher adalimumab levels are associated with histologic and endoscopic remission in patients with Crohn\u2019s disease and ulcerative colitis. Inflamm Bowel Dis. 2016;22(2):409\u201315. https:\/\/doi.org\/10.1097\/mib.0000000000000689.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"637_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/gut.53.1.1","volume":"53","author":"CP Tamboli","year":"2004","unstructured":"Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut. 2004;53(1):1\u20134. https:\/\/doi.org\/10.1136\/gut.53.1.1.","journal-title":"Gut"},{"issue":"1","key":"637_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","volume":"11","author":"A Nishida","year":"2018","unstructured":"Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11(1):1\u201310. https:\/\/doi.org\/10.1007\/s12328-017-0813-5.","journal-title":"Clin J Gastroenterol"},{"key":"637_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.620724","volume":"11","author":"L Dai","year":"2020","unstructured":"Dai L, Tang Y, Zhou W, Dang Y, Sun Q, Tang Z, et al. Gut microbiota and related metabolites were disturbed in ulcerative colitis and partly restored after mesalamine treatment. Front Pharmacol. 2020;11: 620724. https:\/\/doi.org\/10.3389\/fphar.2020.620724.","journal-title":"Front Pharmacol"},{"issue":"2","key":"637_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148241","volume":"11","author":"Y Cui","year":"2016","unstructured":"Cui Y, Wei H, Lu F, Liu X, Liu D, Gu L, et al. Different effects of three selected Lactobacillus strains in dextran sulfate sodium-induced colitis in BALB\/c mice. PLoS ONE. 2016;11(2): e0148241. https:\/\/doi.org\/10.1371\/journal.pone.0148241.","journal-title":"PLoS ONE"},{"key":"637_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.612285","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wu J, Lv M, Shao Z, Hungwe M, Wang J, et al. Metabolism characteristics of lactic acid bacteria and the expanding applications in food industry. Front Bioeng Biotechnol. 2021;9: 612285. https:\/\/doi.org\/10.3389\/fbioe.2021.612285.","journal-title":"Front Bioeng Biotechnol"},{"key":"637_CR35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/srep00332","volume":"2","author":"A Kojima","year":"2012","unstructured":"Kojima A, Nakano K, Wada K, Takahashi H, Katayama K, Yoneda M, et al. Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis. Sci Rep. 2012;2:332. https:\/\/doi.org\/10.1038\/srep00332.","journal-title":"Sci Rep"},{"key":"637_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/ncomms1491","volume":"2","author":"K Nakano","year":"2011","unstructured":"Nakano K, Hokamura K, Taniguchi N, Wada K, Kudo C, Nomura R, et al. The collagen-binding protein of Streptococcus mutans is involved in haemorrhagic stroke. Nat Commun. 2011;2:485. https:\/\/doi.org\/10.1038\/ncomms1491.","journal-title":"Nat Commun"},{"issue":"1","key":"637_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.5217\/ir.2021.00168","volume":"21","author":"SY Shin","year":"2023","unstructured":"Shin SY, Kim Y, Kim WS, Moon JM, Lee KM, Jung SA, et al. Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease. Intest Res. 2023;21(1):148\u201360. https:\/\/doi.org\/10.5217\/ir.2021.00168.","journal-title":"Intest Res"},{"issue":"1","key":"637_CR38","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1038\/s41598-018-23571-4","volume":"8","author":"T Bazin","year":"2018","unstructured":"Bazin T, Hooks KB, Barnetche T, Truchetet ME, Enaud R, Richez C, et al. Microbiota composition may predict anti-Tnf alpha response in spondyloarthritis patients: an exploratory study. Sci Rep. 2018;8(1):5446. https:\/\/doi.org\/10.1038\/s41598-018-23571-4.","journal-title":"Sci Rep"},{"issue":"12","key":"637_CR39","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1080\/00365521.2016.1216587","volume":"51","author":"M Prosberg","year":"2016","unstructured":"Prosberg M, Bendtsen F, Vind I, Petersen AM, Gluud LL. The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis. Scand J Gastroenterol. 2016;51(12):1407\u201315. https:\/\/doi.org\/10.1080\/00365521.2016.1216587.","journal-title":"Scand J Gastroenterol"},{"key":"637_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.953962","volume":"12","author":"S Zhu","year":"2022","unstructured":"Zhu S, Han M, Liu S, Fan L, Shi H, Li P. Composition and diverse differences of intestinal microbiota in ulcerative colitis patients. Front Cell Infect Microbiol. 2022;12: 953962. https:\/\/doi.org\/10.3389\/fcimb.2022.953962.","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"637_CR41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/003655201750163079","volume":"36","author":"M Chiba","year":"2001","unstructured":"Chiba M, Hoshina S, Kono M, Tobita M, Fukushima T, Iizuka M, et al. Staphylococcus aureus in inflammatory bowel disease. Scand J Gastroenterol. 2001;36(6):615\u201320. https:\/\/doi.org\/10.1080\/003655201750163079.","journal-title":"Scand J Gastroenterol"},{"key":"637_CR42","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3389\/fmicb.2016.00979","volume":"7","author":"A Rivi\u00e8re","year":"2016","unstructured":"Rivi\u00e8re A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol. 2016;7:979. https:\/\/doi.org\/10.3389\/fmicb.2016.00979.","journal-title":"Front Microbiol"},{"issue":"3","key":"637_CR43","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/jgh.15232","volume":"36","author":"S Kedia","year":"2021","unstructured":"Kedia S, Ghosh TS, Jain S, Desigamani A, Kumar A, Gupta V, et al. Gut microbiome diversity in acute severe colitis is distinct from mild to moderate ulcerative colitis. J Gastroenterol Hepatol. 2021;36(3):731\u20139. https:\/\/doi.org\/10.1111\/jgh.15232.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-024-00637-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-024-00637-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-024-00637-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T18:02:33Z","timestamp":1724695353000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-024-00637-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["637"],"URL":"https:\/\/doi.org\/10.1186\/s13099-024-00637-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3957225\/v1","asserted-by":"object"}]},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript has not been published or presented elsewhere in part or in entirety and is not under consideration by another journal. This study was performed in accordance with the principles of the Declaration of Helsinki and approved by the Institutional Review Board of Chung-Ang University Hospital (IRB No. C2015020). Written informed consent was obtained from each participant before inclusion into the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}